Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Georgia Bard's Corner -- Ignore unavailable to you. Want to Upgrade?

To: Big Dog who wrote (4698)	8/17/1998 6:14:00 PM
From: Gator	Respond to of 9440

Time for a group hug. And a group pick (like RESY). Earnings expected this week. Tiny float, great little company. Super balance sheet (no l.t. debt, 3.5:1 current ratio, PE around 9). Very undervalued, looks like an attractive takeover candidate as well. Here's some DD I put together a couple of weeks ago. Have since talked to the company. They're pretty conservative and focused on steady, controlled growth. Here's the DD: RESY - Reconditioned Systems, Inc. Nasdaq Small-Cap. $4 - $4 5/16 (now $4 3/8 to $4 5/8). Shares Outstanding: 1,473,950 Shares in Float: 500,000 PE: 8.1 1998 Revenues (year-end March 31): $9.6 million, up 35% from 1997 revenues of $7.1 million. 1998 EPS (fully diluted): $0.52 vs. $0.16 in 1997. No long term debt. Current ratio about 3.5:1. Next earnings release: Week of August 17, 1998. RESY purchases used modular office work stations from manufacturers, dealers, brokers and end-users; and then reconditions and markets the work stations. They focus primarily on Haworth line of office furniture, which is the "Cadillac" of office furnishings. Very small float, moves on little volume. PE of 20 would put the stock at $11 3/8 based on trailing 12 month earnings. Forward split isn't out of the question if the stock runs to $8-$10 to increase market liquidity (the company is cognizant of the fact that they probably don't have enough shares outstanding right now). Rumored to be a takeover target, Haworth has been mentioned as a candidate. No coverage on SI, only a handful of messages on Yahoo message board. Web site: resy.net Gator

To: Big Dog who wrote (4698)	8/17/1998 9:50:00 PM
From: LaShark	Read Replies (1) \| Respond to of 9440

AGISS NEWS, AGCR. This company is worth a look. go2net.newsalert.com AGISS Forms Software Company, Biochemical Computing Incorporated PR Newswire - August 17, 1998 15:49 OTTAWA, Aug. 17 /PRNewswire/ -- AGISS Corporation (OTC Bulletin Board: AGCR) announces today the formation of Biochemical Computing Incorporated, a wholly owned subsidiary of AGISS Corporation. Biochemical Computing is a software research and development company, focusing on a product that analyzes the toxicological hazards of drugs or chemicals on living organisms. "Biochemical Computing is an exciting venture for AGISS Corporation," said Robert Sowah, CEO. "The software developed by Biochemical Computing, which is being tested today at beta sites, will substantially cut the time-to-market for drug and chemical companies by reducing the amount of testing required. The software will also reduce the amount of animal testing required by drug and cosmetic companies." "Drug and chemical testing is a multi-billion dollar industry," says Anicet Blais, President, "and as one of AGISS Corporations core competencies, the Biochemical Computing software is hoping to carve out a niche for itself." AGISS Software Corporation is a leading provider of automated conversion tools and services to solve the Year 2000 conversion across many different platforms. Its Canadian methodology for correcting the Millennium problem is called REMEDY2000(TM) and is marketed worldwide. AGISS Software focuses on Year 2000 conversion, Euro Conversion, software development and system integration. The following is a "safe harbor" statement under the private Securities Litigation Reform Act of 1995: "This release may contain forward-looking statements that involve risks and uncertainties which might cause the actual results to differ materially from those projected in any forward-looking statements. Factors, which could affect actual results include the development and introduction of competitive technologies, the overall market demand for conversion services, the presence of technologically-inferior products and services which are priced or promoted to compete with AGISS." SOURCE AGISS Corporation /CONTACT: Thomas M. Dean or Michael Block, both of Murdock Capital Partners Corp., 212-421-2545, for AGISS Corporation/ (AGCR)

To: Big Dog who wrote (4698)	8/18/1998 2:09:00 PM
From: Gator	Respond to of 9440

RESY came out with earnings (up 60%!). News release not out yet, but numbers are on Edgar. Here's the details: (3 months ending June 30th, 1998 vs. June 30th, 1997) Revenue: $2,653,092 vs. $2,267,362 (up 17%) Net Income: $242,547 vs. $148,808 (up 62.9%) EPS: $0.16 vs. $0.10 (up 60%) EPS (diluted): $0.14 vs. $0.09 (up 56%) Shares Out: 1,473,950 vs. 1,473,950 Fully diluted shares outstanding: 1,691,411 vs. 1,578,510 Current ratio improved to 3.7:1 compared to 3.5:1 last quarter and 2.7:1 last year. Book value improved to $1.67/share, vs. $1.50 last quarter and $1.03 last year. The company still has $2.1 million left in Federal Tax Loss carryovers and $1.9 million in state tax loss carryovers. No material long term debt. Untapped $1 million line of credit thru M&I Bank. Company has stated that they will begin a conservative acquisition program to accelerate sales (internal growth rate 15-20%). Great Numbers! Gator